BlackRock, Inc. 13D and 13G filings for Vir Biotechnology, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-04-28 1:02 pm Sale | 2025-03-31 | 13G | Vir Biotechnology, Inc. VIR | BlackRock Inc. BLK | 14,826,039 10.800% | -2,038,540 (-12.09%) | Filing |
| 2024-01-23 4:14 pm Purchase | 2023-12-31 | 13G | Vir Biotechnology, Inc. VIR | BlackRock Inc. BLK | 16,864,579 12.500% | 2,727,951 (+19.30%) | Filing |
| 2023-01-24 1:56 pm Purchase | 2022-12-31 | 13G | Vir Biotechnology, Inc. VIR | BlackRock Inc. BLK | 14,136,628 10.600% | 752,434 (+5.62%) | Filing |
| 2022-09-08 1:43 pm Purchase | 2022-08-31 | 13G | Vir Biotechnology, Inc. VIR | BlackRock Inc. BLK | 13,384,194 10.100% | 13,384,194 (New Position) | Filing |